首页> 外文OA文献 >Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study
【2h】

Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study

机译:患有抗癫痫药物的危重儿童药物诱导的肝损伤:回顾性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ABSTRACT: Background: Antiepileptic drugs are among the leading causes of drug-induced liver injury (DILI). Due to critical illness, children admitted to intensive care units are more prone to DILI. Objective: We attempted to elucidate the association between antiepileptic drug use and the associated factors resulting in DILI in a pediatric intensive care unit of a tertiary care hospital. Methods: We carried out an observational retrospective study on children receiving antiepileptic drugs. Details on their demographic characteristics, drugs, serum levels of antiepileptic drugs and liver function tests, and hospital stay were recorded. Council for International Organizations of Medical Sciences definitions were adhered to when defining DILI. LiverTox (https://livertox.nih.gov) and DILIrank were used to assess the risks of hepatotoxicity of the concomitant drugs. Regression models were developed for predicting DILI. Results: Five out of 9 patients taking phenobarbitone (55.6%), 9 out of 12 taking phenytoin monotherapy (75%), 7 out of 10 taking phenytoin/phenobarbitone (70%), all 3 receiving phenytoin/phenobarbitone/valproate sodium, and 1 with phenytoin/carbamazepine developed DILI either in the form of hepatocellular injury or liver biochemical test abnormalities. None of the patients had cholestatic or mixed type of liver injury. All the critically ill children received at least 2 concomitant drugs with hepatotoxic potential. Concomitant category B hepatotoxic drugs and toxic drug levels were significantly associated with increased risk of DILI. Similarly, a trend was observed for less-DILI-concern concomitant drug class and toxic drug levels when the drugs were analyzed by DILIrank classification. Conclusions: A significant proportion of critically ill children taking antiepileptic drugs experience DILI. Guidelines recommending use of drugs with reduced risk of potential hepatotoxicity for various concomitant disease states in such children admitted to intensive care units receiving antiepileptic drugs are urgently needed.
机译:摘要:背景:抗癫痫药物是药物诱导的肝损伤(DILI)的主要原因。由于危重疾病,录取了深入护理单位的儿童更容易发生Dili。目的:我们试图阐明抗癫痫药物使用与第三节护理医院儿科重症监护单位中帝力的相关因素之间的关联。方法:我们对接受抗癫痫药物的儿童进行了一个观测到的回顾性研究。记录有关其人口特征,药物,血清抗癫痫药物和肝功能试验以及住院住宿的详细信息。在定义Dili时,遵守国际医学科学的国际组织理事会。 Livertox(https://livertox.nih.gov)和dilirank用于评估伴随药物的肝毒性的风险。为预测Diri开发了回归模型。结果:9例患者中的5例服用苯甲腺苷(55.6%),12名以12种以苯妥林单药治疗(75%),10分别为10次服用苯妥辛/苯巴西酮(70%),所有3种接受苯妥林/苯巴西酮/丙戊糖钠,以及1用苯妥辛/卡巴马嗪开发的稀脂或肝细胞损伤或肝脏生化试验异常的形式。没有患者没有胆汁淤积或混合类型的肝损伤。所有批判性病的孩子都接受了至少2种具有肝毒性潜力的伴随药物。伴随物类别B类肝毒性药物和有毒药物水平与帝力的风险增加显着相关。同样,当药物分析稀释剂分类时,观察到较少的稀释剂伴随的药物类和有毒药物水平的趋势。结论:患有抗癫痫药物的危重儿童的重要比例患者体验Dili。迫切需要推荐使用药物使用药物的指导方针,这种儿童在接受接受抗癫痫药物的密集护理单位的儿童中占各种伴随疾病状态的潜在肝毒性的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号